Publications dans lesquelles il/elle collabore avec PALOMA MARTÍN SANZ (127)

2023

  1. Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair

    Purinergic Signalling

2022

  1. COX-2 Expression in Hepatocytes Improves Mitochondrial Function after Hepatic Ischemia-Reperfusion Injury

    Antioxidants, Vol. 11, Núm. 9

  2. Functional Crosstalk between PCSK9 Internalization and Pro-Inflammatory Activation in Human Macrophages: Role of Reactive Oxygen Species Release

    International journal of molecular sciences, Vol. 23, Núm. 16

  3. High-fat diet activates splenic NOD1 and enhances neutrophil recruitment and neutrophil extracellular traps release in the spleen of ApoE-deficient mice

    Cellular and Molecular Life Sciences, Vol. 79, Núm. 8

  4. Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals

    Hepatology, Vol. 75, Núm. 3, pp. 550-566

  5. NOD1 splenic activation confers ferroptosis protection and reduces macrophage recruitment under pro-atherogenic conditions

    Biomedicine and Pharmacotherapy, Vol. 148

  6. Quantitative Proteomics Analysis Reveals That Cyclooxygenase-2 Modulates Mitochondrial Respiratory Chain Complex IV in Cardiomyocytes

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  7. Unraveling the interplay between iron homeostasis, ferroptosis and extramedullary hematopoiesis

    Pharmacological Research, Vol. 183

2021

  1. Beyond classic concepts in thyroid homeostasis: Immune system and microbiota

    Molecular and Cellular Endocrinology, Vol. 533

  2. Chronic treatment with acetaminophen protects against liver aging by targeting inflammation and oxidative stress

    Aging, Vol. 13, Núm. 6, pp. 7800-7827

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. NOD1 in the interplay between microbiota and gastrointestinal immune adaptations

    Pharmacological Research, Vol. 171

  5. Nod1-targeted immunonutrition approaches: On the way from disease to health

    Biomedicines, Vol. 9, Núm. 5

2020

  1. Contribution of Extramedullary Hematopoiesis to Atherosclerosis. The Spleen as a Neglected Hub of Inflammatory Cells

    Frontiers in Immunology, Vol. 11

  2. Deletion or Inhibition of NOD1 Favors Plaque Stability and Attenuates Atherothrombosis in Advanced Atherogenesis †

    Cells, Vol. 9, Núm. 9

  3. NOD1 deficiency promotes an imbalance of thyroid hormones and microbiota homeostasis in mice fed high fat diet

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1

    FASEB Journal, Vol. 33, Núm. 3, pp. 3912-3921

  2. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort

    World Journal of Gastroenterology, Vol. 25, Núm. 4, pp. 433-446

  3. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia–Reperfusion Injury in Mice

    Hepatology, Vol. 70, Núm. 2, pp. 650-665

2018

  1. Benzylamine and thenylamine derived drugs induce apoptosis and reduce proliferation, migration and metastasis formation in melanoma cells

    Frontiers in Oncology, Vol. 8, Núm. AUG